November 17, 2022
FDA: Class I recall of Insulet Omnipod DASH PDM
Editor's Note
The Food and Drug Administration (FDA) on November 16 identified the recall by Insulet of its Omnipod DASH Insulin Management System Personal Diabetes Manager (PDM) as Class I, the most serious.
The recall was initiated because of PDM battery issues, including:
- Battery swelling
- Fluid leakage from the battery
- Extreme overheating that may pose a fire hazard.
The company reports 455 complaints, three fires, and no injuries or deaths.
Distribution dates were July 27, 2018, to August 31, 2022.
Free Daily News
- Value assessment of a trauma hybrid OR
- SHEA: Strategies to prevent SSIs updated
- FDA: Class I recall of Draeger Medical’s Seattle PAP Plus, breathing circuit/anesthesia kits
- Surgeon-scientists represent less than 2% of all investigators awarded NIH funding
- New EHR generative AI by Microsoft, Epic currently being piloted
- Development of a definition for long COVID
- The Joint Commission seeking comments on proposed new infection control requirements for hospitals, critical access hospitals
- Using human-AI collaboration to monitor PPE donning, doffing
- The Joint Commission: Licensed independent practitioner term eliminated from AHC, OBS accreditation programs
- Projected growth of nursing, OR-related occupations 2021-2031
© Access Intelligence, LLC. All rights reserved. | Privacy Policy | Diversity Inclusion & Equity